• Home
  • The University of British Columbia
  • Research Methods
  • Medicalization of Shyness into Social Anxiety Disorder

Medicalization of Shyness into Social Anxiety Disorder

Gaurangi Oberoi In- class writing 13th September 2023 1. Shyness has been medicalized into the condition known as social anxiety disorder (SAD), despite being a common personality feature or disposition. Extreme fear of social situations is the characteristic of social anxiety disorder, which can cause serious suffering and hinder everyday functioning. 2. The advantages and disadvantages of having social anxiety disorder are as follows: Benefits: Access to Treatment: Healthcare may give people access to care and assistance. SAD sufferers may benefit from treatment and, in certain instances, medications to treat their symptoms. Validation: Receiving an illness diagnosis may help some people feel more validated about their circumstances and less stigmatized. It aids them in realizing that their difficulties are not merely a reflection of their own shortcomings. Downsides: Overdiagnosis and overmedication: There is a risk of excessive diagnosis and overmedication, in which people who might not fulfill the clinical criteria for SAD are identified and treated, perhaps subjecting them to unneeded treatments and side effects. Stigmatization: Medicalizing shyness has the potential to stigmatize shy people since they may be mistakenly labeled as "ill" or "normal" rather than as people with a distinct temperament. 3. Benefits: Professional Recognition: Studying and treating disorders like social anxiousness disorder earns researchers and doctors funding and recognition. Opportunities for Treatment: Medicalization opens doors for therapists, counselors, and pharmaceutical firms to design and offer therapies, perhaps resulting in financial gain. Downsides: Overpathologizing: A medicalization of behavior may result in the exaggeration of common human experience differences. This can lead to the needless labeling of individuals and the potential for harm by providing therapies they may not require. Influence of the pharmaceutical business: The pharmaceutical industry might have an ownership stake in medicalizing some problems, which could result in an excessive prescription of pharmaceuticals as a primary form of therapy, even when alternative types of intervention might be more suitable.